Aclarion (ACONW) Competitors $0.04 0.00 (0.00%) (As of 12/6/2024) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends ACONW vs. AVHIW, AVHIU, AONC, DHACW, CORBF, LFMDP, OTRKP, PIIIW, TALKW, and TOIIWShould you be buying Aclarion stock or one of its competitors? The main competitors of Aclarion include Achari Ventures Holdings Corp. I (AVHIW), Achari Ventures Holdings Corp. I (AVHIU), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Global Cord Blood (CORBF), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), Talkspace (TALKW), and Oncology Institute (TOIIW). These companies are all part of the "healthcare" industry. Aclarion vs. Achari Ventures Holdings Corp. I Achari Ventures Holdings Corp. I American Oncology Network Digital Health Acquisition Global Cord Blood LifeMD Ontrak P3 Health Partners Talkspace Oncology Institute Achari Ventures Holdings Corp. I (NASDAQ:AVHIW) and Aclarion (NASDAQ:ACONW) are both financial services companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, community ranking, analyst recommendations, media sentiment, dividends, risk, valuation, profitability and institutional ownership. Is AVHIW or ACONW more profitable? Company Net Margins Return on Equity Return on Assets Achari Ventures Holdings Corp. IN/A N/A N/A Aclarion N/A N/A N/A Does the MarketBeat Community prefer AVHIW or ACONW? Achari Ventures Holdings Corp. I and Aclarion both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAchari Ventures Holdings Corp. IN/AN/AAclarionN/AN/A Which has stronger earnings & valuation, AVHIW or ACONW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAchari Ventures Holdings Corp. IN/AN/AN/AN/AN/AAclarion$49.29KN/AN/AN/AN/A Does the media refer more to AVHIW or ACONW? In the previous week, Achari Ventures Holdings Corp. I's average media sentiment score of 0.00 equaled Aclarion'saverage media sentiment score. Company Overall Sentiment Achari Ventures Holdings Corp. I Neutral Aclarion Neutral SummaryAclarion beats Achari Ventures Holdings Corp. I on 1 of the 1 factors compared between the two stocks. Ad Priority GoldTrump Won, But Can He Save Your 401(k)?Trump Won, But Your Savings Are Still In Danger It's the ONLY playbook that shows you how to fortify your financial future against the chaos that's coming.Click here to get your copy now—before it's too late. Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACONW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACONW vs. The Competition Export to ExcelMetricAclarionHealth Information Services IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$235.50M$5.29B$9.16BDividend YieldN/A6.58%5.63%4.06%P/E RatioN/A783.90132.3017.58Price / SalesN/A277.411,237.73164.96Price / CashN/A37.0434.9335.62Price / BookN/A4.554.834.97Net IncomeN/A-$5.65M$117.40M$224.59M7 Day PerformanceN/A3.29%0.92%1.32%1 Month PerformanceN/A11.10%-0.30%6.30%1 Year PerformanceN/A12.22%33.77%29.33% Aclarion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACONWAclarionN/A$0.04flatN/AN/A$0.00$49,289.000.007AVHIWAchari Ventures Holdings Corp. IN/A$0.01flatN/AN/A$0.00N/A0.003AVHIUAchari Ventures Holdings Corp. IN/A$10.00flatN/AN/A$0.00N/A0.003AONCAmerican Oncology NetworkN/A$4.59+5.5%N/A-25.5%$0.00$1.34B0.001,520DHACWDigital Health AcquisitionN/A$0.05-16.6%N/A+400.0%$0.00N/A0.00N/AGap DownCORBFGlobal Cord BloodN/A$1.26flatN/A-15.4%$0.00$196.12M0.001,202LFMDPLifeMDN/A$22.73+0.6%N/A+20.5%$0.00$193.06M0.00230News CoveragePositive NewsOTRKPOntrakN/A$0.28flatN/A-55.8%$0.00$10.84M0.00250Gap UpPIIIWP3 Health PartnersN/A$0.01flatN/AN/A$0.00$1.48B0.00500Positive NewsGap UpTALKWTalkspaceN/A$0.14+7.8%N/A+27.4%$0.00$181.29M0.00500Gap DownTOIIWOncology InstituteN/A$0.01-35.4%N/AN/A$0.00$378.93M0.00660Gap Down Related Companies and Tools Related Companies AVHIW Alternatives AVHIU Alternatives AONC Alternatives DHACW Alternatives CORBF Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives TOIIW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACONW) was last updated on 12/10/2024 by MarketBeat.com Staff From Our PartnersThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump Won, But Can He Save Your 401(k)?Trump Won, But Your Savings Are Still In Danger It's the ONLY playbook that shows you how to fortify your f...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVanguard issues correction warningThe S&P just notched another record close... Apple and Meta are leading the Nasdaq to extraordinary new hei...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
